CAD 0.43
(6.25%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -20.72 Million CAD | -38.15% |
2022 | -16.12 Million USD | -0.45% |
2021 | -16.04 Million CAD | -37.54% |
2020 | -11.66 Million CAD | 10.38% |
2019 | -13.01 Million CAD | -11201.36% |
2018 | -115.2 Thousand CAD | 6.68% |
2017 | -123.44 Thousand CAD | 10.01% |
2016 | -137.17 Thousand CAD | 25.62% |
2015 | -184.42 Thousand CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -4.52 Million USD | 4.25% |
2024 Q2 | -5.21 Million USD | -15.26% |
2023 Q2 | -2.9 Million USD | 22.08% |
2023 Q1 | -3.72 Million USD | 5.08% |
2023 FY | -22.27 Million CAD | -38.15% |
2023 Q4 | -4.72 Million USD | -13.05% |
2023 Q3 | -4.18 Million USD | -44.14% |
2022 Q3 | -5.77 Million CAD | 5.26% |
2022 Q1 | -4.82 Million CAD | 12.13% |
2022 Q2 | -6.09 Million CAD | -26.32% |
2022 FY | -16.12 Million USD | -0.45% |
2022 Q4 | -3.92 Million USD | 32.01% |
2021 Q1 | -3.79 Million CAD | 9.86% |
2021 Q2 | -3.03 Million CAD | 20.14% |
2021 Q3 | -3.72 Million CAD | -22.76% |
2021 Q4 | -5.48 Million CAD | -47.3% |
2021 FY | -16.04 Million CAD | -37.54% |
2020 Q1 | -1.71 Million CAD | 33.32% |
2020 Q3 | -2.18 Million CAD | -12.01% |
2020 Q4 | -4.21 Million CAD | -92.94% |
2020 Q2 | -1.95 Million CAD | -14.02% |
2020 FY | -11.66 Million CAD | 10.38% |
2019 Q1 | -1.56 Million CAD | 0.0% |
2019 FY | -13.01 Million CAD | -11201.36% |
2019 Q4 | -2.56 Million CAD | -12.43% |
2019 Q3 | -2.28 Million CAD | -5.96% |
2019 Q2 | -2.15 Million CAD | -37.79% |
2018 FY | -115.2 Thousand CAD | 6.68% |
2017 FY | -123.44 Thousand CAD | 10.01% |
2016 FY | -137.17 Thousand CAD | 25.62% |
2015 FY | -184.42 Thousand CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Therma Bright Inc. | -3.6 Million CAD | -475.325% |
Theralase Technologies Inc. | -4.59 Million CAD | -351.209% |
VentriPoint Diagnostics Ltd. | -4.93 Million CAD | -320.439% |